Free. Unsubscribe any time.
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. filed 14 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 81 transactions and 227,669 shares. None carries the SEC's AFF10B5ONE flag; all 14 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-02-06, came 128 days after the one before it (2025-10-01) and reports 8 transactions against 9 in the filing before it.
- The sales it reports total 5,961 shares, 648 fewer than the 6,609 in the filing before it.
- Its 14 plan statements rank 335th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 14 filings on file run from 2025-01-06 to 2026-02-06, and state 3 plan adoption dates, from 2024-08-16 to 2025-09-15.
Trades in GeneDx Holdings Corp. 81
- Feeley Kevin — 2025-01-02 · S · 319 shares
- Feeley Kevin — 2025-01-02 · S · 774 shares
- Feeley Kevin — 2025-01-02 · S · 337 shares
- Stueland Katherine — 2025-01-02 · S · 2,654 shares
- Stueland Katherine — 2025-01-02 · S · 2,051 shares
- Stueland Katherine — 2025-01-02 · S · 3,417 shares
- Stueland Katherine — 2025-01-02 · S · 4,078 shares
- Stueland Katherine — 2025-01-02 · S · 4,242 shares
- Stueland Katherine — 2025-01-02 · S · 1,564 shares
- Feeley Kevin — 2025-01-07 · S · 24,073 shares
- Feeley Kevin — 2025-01-07 · S · 7,078 shares
- Feeley Kevin — 2025-01-07 · S · 3,455 shares
Adoption dates in GeneDx Holdings Corp. 3
- 2024-08-16 — stated in 6 filings
- 2024-08-21 — stated in 7 filings
- 2025-09-15 — stated in 1 filing
Results prints in GeneDx Holdings Corp. 9
- 2025-01-13
- 2025-02-18
- 2025-04-30
- 2025-07-29
- 2025-10-28
- 2026-01-12
- 2026-02-23
- 2026-05-04
- 2026-08-03
Trades before a print in GeneDx Holdings Corp. 0
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Feeley Kevin · 24,073 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Feeley Kevin · 7,078 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Feeley Kevin · 3,455 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Feeley Kevin · 900 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Stueland Katherine · 23,800 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Stueland Katherine · 8,439 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Stueland Katherine · 9,176 shares
- 6 days before the 2025-01-13 print — 2025-01-07 · S · Stueland Katherine · 10,005 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Feeley Kevin · 319 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Feeley Kevin · 774 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Feeley Kevin · 337 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Stueland Katherine · 2,654 shares
Interval to GeneDx Holdings Corp.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 8within 10 days
- 6shortest, days
- 0no later print
- Feeley Kevin 2025-01-07 · S · 6 days before the 2025-01-13 print · CHIEF FINANCIAL OFFICER
- Feeley Kevin 2025-01-07 · S · 6 days before the 2025-01-13 print · CHIEF FINANCIAL OFFICER
- Feeley Kevin 2025-01-07 · S · 6 days before the 2025-01-13 print · CHIEF FINANCIAL OFFICER
- Feeley Kevin 2025-01-07 · S · 6 days before the 2025-01-13 print · CHIEF FINANCIAL OFFICER
- Stueland Katherine 2025-01-07 · S · 6 days before the 2025-01-13 print · Chief Executive Officer
- Stueland Katherine 2025-01-07 · S · 6 days before the 2025-01-13 print · Chief Executive Officer
- Stueland Katherine 2025-01-07 · S · 6 days before the 2025-01-13 print · Chief Executive Officer
- Stueland Katherine 2025-01-07 · S · 6 days before the 2025-01-13 print · Chief Executive Officer
Adoption dates GeneDx Holdings Corp. states
- 2024-08-16 in 6 filings
- 2024-08-21 in 7 filings
- 2025-09-15 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on August 21, 2024”
Reported results dates on file
- 2025-01-13
- 2025-02-18
- 2025-04-30
- 2025-07-29
- 2025-10-28
- 2026-01-12
- 2026-02-23
- 2026-05-04
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- HCA Healthcare, Inc. 1
- LABCORP HOLDINGS INC. 26
- DAVITA INC. 3
- QUEST DIAGNOSTICS INC 37
- EXACT SCIENCES CORP 10
- ENSIGN GROUP, INC 48
- CareDx, Inc. 22
- VERACYTE, INC. 44
- CASTLE BIOSCIENCES INC 67
- Teladoc Health, Inc. 11
Sources: SEC EDGAR full-text search and the SEC submissions API.